Scientific deep-dive
Food Noise: A Patient’s Word That Now Has a Questionnaire
Patients coined the term and the literature followed. It now has a validated five-item instrument, and a 2026 commentary arguing it may not describe anything distinct.
“Food noise” started with patients, not clinicians. People managing their weight coined it, it spread, and the literature followed. Since 2025 it has had a validated instrument, a five-item questionnaire with excellent internal consistency, and by 2026 a second one from another team.[1][7] What it does not yet have is agreement that it describes something distinct from constructs psychology already had names for, and a 2026 commentary makes that case at length.[4] Both matter when you decide what your own experience of it means.
What people mean by it
The description that recurs is a constant preoccupation with food decisions (what to eat, how much, when, how it balances against everything else eaten that day) that becomes intrusive rather than pleasurable.[3] It is the background process, not the appetite. People describe planning the next meal during the current one.
The reason it caught on is that it named a burden nobody had a word for. A 2025 review puts it plainly: the term was popularized by people managing their own weight, it appears to affect cognitive load and quality of life, and it is now cited as one reason weight-loss attempts fail.[3] If the exhausting part of dieting is the mental overhead rather than the hunger, a drug that quiets the overhead is doing something the older drugs did not.
It now has an instrument
In 2025 researchers built and tested the Food Noise Questionnaire, because, as they note, no validated way to measure it existed despite all the attention.[1] Four hundred participants completed it; a subsample repeated it a week later, and another completed established food-preoccupation, mood, anxiety and stress measures alongside.
| Property | Result | What it means |
|---|---|---|
| Internal consistency | Cronbach α = 0.93 | The five items behave as one coherent scale |
| Test-retest reliability | r = 0.79 over ~7 days | It measures something stable, not a mood that day |
| Structure | Five items, a single factor | One construct, not several bundled together |
| Discriminant validity | Tested against mood, anxiety and stress | It is not simply picking up general distress |
That is a real piece of work and it changes the conversation, because a thing that can be measured can be studied. Validation establishes something narrower: that the questionnaire reliably measures something, and that the something is not just anxiety. It does not establish that the something is a distinct condition.
The questionnaire has since been translated and retested. An Italian version given to 1,087 adults in 2026 kept the single-factor structure and strong reliability. It also correlated at r = 0.831 with an existing measure of food preoccupation, against 0.35 to 0.42 with anxiety, depression and stress.[6] That first correlation is the skeptics’ argument expressed as a number. Whatever the scale captures sits very close to something psychology was already measuring.
Self-identification with the term is widespread. A nationally representative US survey of 1,000 adults in May 2026 asked a single question about it: 50.89% reported food noise at least occasionally and 17.98% frequently. Frequent food noise was more common among current and former GLP-1 users (25.76% and 26.78%) than among non-users (16.30%). The strongest independent predictor was reported loss of control over eating, at an odds ratio of 5.95.[5] One cross-sectional item cannot say whether the drugs relieve food noise, provoke it, or attract the people who have it.
The trials measured it before it had a name
Long before anyone said food noise, the semaglutide trials were administering a 19-item Control of Eating Questionnaire, which asks about craving intensity, difficulty resisting, and control. STEP 5 ran that instrument for 104 weeks.[2]
In the subgroup completing it, weight fell 14.8% on semaglutide against 2.4% on placebo. Craving Control and Craving for Savory improved significantly at weeks 20, 52 and 104. By two years, desire to eat salty and spicy food, cravings for dairy and starchy foods, difficulty resisting cravings, and control of eating had all significantly improved against placebo. The craving improvements also correlated with how much weight came off.[2]
The case against the concept
A 2026 commentary in Appetite takes the construct apart, and it deserves reading rather than dismissing. Its argument is that food noise entered scientific, clinical, commercial and public discourse simultaneously; that evidence on its underlying mechanisms is limited; and that it is not established whether it reflects a distinct phenomenon at all, as against food cue reactivity, food preoccupation, cravings and intrusive food-related cognitions, each of which already has its own literature.[4]
Food noise entered scientific, clinical, commercial and public discourse at the same time.
A term can be useful to patients and still not name a distinct thing, and we think both are true here. The term does real work: it lets someone describe an experience clinicians were not asking about. But a construct that arrives with commercial interest attached, and whose measurement tools appear at the same moment as the drugs that are said to fix it, is one to hold loosely.
What this means for you
If the constant mental negotiation about food has quieted on a GLP-1, that experience is real and is now measurable, and reporting it is useful to whoever is treating you. If it has not quieted, that does not mean the drug is failing. The weight-loss trials did not measure food noise, and nobody has shown that quieting it is the mechanism.
And if the noise is the part of eating that troubles you most, raise it with a clinician rather than relying on the drug alone. Intrusive food thoughts sit close to disordered eating, and the two need different help. For what the drugs demonstrably do to weight over time, our semaglutide timeline and tirzepatide timeline set out the trial record, and what happens when you stop covers what returns. Why appetite comes back after a last semaglutide dose is covered in stopping Ozempic or Wegovy.
Frequently Asked Questions
References
- 1.Diktas HE, Cardel MI, Foster GD, et al. Development and validation of the Food Noise Questionnaire Obesity. 2025. PMID: 39828656.
- 2.Wharton S, Batterham RL, Bhatta M, et al. Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5 Obesity. 2023. PMID: 36655300.
- 3.Dhurandhar EJ, Maki KC, Dhurandhar NV, et al. Food noise: definition, measurement, and future research directions Nutrition & Diabetes. 2025. PMID: 40628707.
- 4.Brewis A, Hayashi D, Gualano B, et al. Food noise: Conceptual, methodological, and ethical considerations Appetite. 2026. PMID: 42392316.
- 5.Hayashi D, Masterson TD Prevalence and Correlates of Perceived Food Noise Among U.S. Adults in a Nationally Representative Sample Obesity Science & Practice. 2026. PMID: 42801078.
- 6.Mocini E, Di Vincenzo O, D'angelo C, et al. Psychometric Properties of the Italian Food Noise Questionnaire (FNQ) for the Assessment of Intrusive Food-Related Thoughts Behavioral Sciences. 2026. PMID: 42073972.
- 7.Dhurandhar EJ, Maki KC, Dhurandhar NV, et al. Development and rigorous multistep validation of a psychometric tool to measure food noise Appetite. 2026. PMID: 41101555.
Compare the sellers
Related research
GLP-1 Drugs and Your Kidneys: Protective Over Years, Risky Over Days
Semaglutide cut the risk of kidney failure, a large drop in kidney function, or death from a kidney or cardiovascular cause by 24% over a median 3.4 years. The label also warns of acute kidney injury in people dehydrated by vomiting or diarrhea. Both are true.
7 min read
GLP-1 Drugs and Headache: A Side Effect, and a Treatment
Headache is in the label’s adverse reactions table at 14% against 10% on placebo. A randomized trial using implanted pressure monitors also found a GLP-1 lowered intracranial pressure within hours.
7 min read
GLP-1 Drugs and Rheumatoid Arthritis: One Study, and What It Cannot Tell You
A retrospective review of 215 patients found greater falls in disease activity and pain among those who took a GLP-1 than among those prescribed one who did not. Nearly a third stopped the drug within the year.
6 min read
Gabapentin and Pregabalin Weight Gain: What the Labels Show, and Where a GLP-1 Fits
Pregabalin (Lyrica) weight gain rises with dose: 9% gained 7% or more in short trials vs 2% on placebo. Gabapentin's label signal is smaller. Neither may be stopped abruptly, and no trial has tested a GLP-1 for this gain.
11 min read
Stopping Ozempic or Wegovy: Side Effects, Weight Regain and Keeping It Off
Stopping Ozempic or Wegovy causes no withdrawal syndrome on either label. Appetite returns as semaglutide clears over about five weeks, and a 2026 BMJ meta-analysis found regain of about 0.8 kg a month. What helps keep weight off, and what women should know.
10 min read
Holding a GLP-1 Before Endoscopy or Surgery: What the Trial Found
A 2026 randomized trial put retained stomach contents at 3.1% when one dose was held against 25.0% when it was not, and found something more useful about the day-before diet.
7 min read
Where to get semaglutide online, safely: sellers our editors have checked
These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
bmiMD
Starting below a standard dose, with microdose tiers
From $129/mo, prepaid
Get started →WellMedRx
Comparing compounded and brand GLP-1 plans with a published state list
From $49/mo
Get started →YourEra
From $99/mo
Get started →